ROCHE HLDGS AGROCHE HLDGS AGROCHE HLDGS AG

ROCHE HLDGS AG

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪205.79 B‬CHF
13.322CHF
‪11.50 B‬CHF
‪58.72 B‬CHF
‪690.10 M‬
Beta (1Y)
1.02
Employees (FY)
‪103.61 K‬
Change (1Y)
−8 −0.01%
Revenue / Employee (1Y)
‪566.73 K‬CHF
Net income / Employee (1Y)
‪110.98 K‬CHF

About ROCHE I


CEO
Thomas Schinecker
Headquarters
Basel
Website
Founded
1896
ISIN
CH0012032048
FIGI
BBG0089X2L65
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
R
CHGCY5317644
Roche Holdings, Inc. 2.607% 13-DEC-2051
Yield to maturity
6.58%
Maturity date
Dec 13, 2051
R
USU75000BT2
ROCHE HLDGS 22/25 REGS
Yield to maturity
5.55%
Maturity date
Mar 10, 2025
R
CHGCY5766485
Roche Holdings, Inc. 5.218% 08-MAR-2054
Yield to maturity
5.36%
Maturity date
Mar 8, 2054
R
CHGCY4184535
Roche Holdings, Inc. 4.0% 28-NOV-2044
Yield to maturity
5.25%
Maturity date
Nov 28, 2044
G
CHGCY3666852
Genentech, Inc. 5.25% 15-JUL-2035
Yield to maturity
5.20%
Maturity date
Jul 15, 2035
R
CHGCY5766483
Roche Holdings, Inc. 4.985% 08-MAR-2034
Yield to maturity
5.19%
Maturity date
Mar 8, 2034
R
CHGCY5766486
Roche Holdings, Inc. 5.218% 08-MAR-2054
Yield to maturity
5.13%
Maturity date
Mar 8, 2054
R
CHGCY5766481
Roche Holdings, Inc. 4.909% 08-MAR-2031
Yield to maturity
5.09%
Maturity date
Mar 8, 2031
R
CHGCY5317198
Roche Holdings, Inc. 2.076% 13-DEC-2031
Yield to maturity
5.06%
Maturity date
Dec 13, 2031
R
USU75000BL9
ROCHE HLDGS 16/27 REGS
Yield to maturity
4.98%
Maturity date
Jan 28, 2027
R
CHGCY5766479
Roche Holdings, Inc. 4.79% 08-MAR-2029
Yield to maturity
4.97%
Maturity date
Mar 8, 2029

Explore more bonds 

Frequently Asked Questions


The current price of RHO5 is 247.695 CHF — it has decreased by −0.65% in the past 24 hours. Watch ROCHE HLDGS AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange ROCHE HLDGS AG stocks are traded under the ticker RHO5.
RHO5 stock has risen by 0.96% compared to the previous week, the month change is a 0.03% rise, over the last year ROCHE HLDGS AG has showed a 0.88% increase.
We've gathered analysts' opinions on ROCHE HLDGS AG future price: according to them, RHO5 price has a max estimate of 440.00 CHF and a min estimate of 230.00 CHF. Watch RHO5 chart and read a more detailed ROCHE HLDGS AG stock forecast: see what analysts think of ROCHE HLDGS AG and suggest that you do with its stocks.
RHO5 reached its all-time high on Apr 11, 2022 with the price of 403.110 CHF, and its all-time low was 213.896 CHF and was reached on May 3, 2024. View more price dynamics on RHO5 chart.
See other stocks reaching their highest and lowest prices.
RHO5 stock is 3.35% volatile and has beta coefficient of 1.02. Track ROCHE HLDGS AG stock price on the chart and check out the list of the most volatile stocks — is ROCHE HLDGS AG there?
Today ROCHE HLDGS AG has the market capitalization of ‪203.18 B‬, it has increased by 0.71% over the last week.
Yes, you can track ROCHE HLDGS AG financials in yearly and quarterly reports right on TradingView.
ROCHE HLDGS AG is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
RHO5 earnings for the last half-year are 10.23 CHF per share, whereas the estimation was 9.37 CHF, resulting in a 9.24% surprise. The estimated earnings for the next half-year are 8.39 CHF per share. See more details about ROCHE HLDGS AG earnings.
ROCHE HLDGS AG revenue for the last half-year amounts to ‪30.76 B‬ CHF, despite the estimated figure of ‪29.61 B‬ CHF. In the next half-year revenue is expected to reach ‪30.62 B‬ CHF.
RHO5 net income for the last half-year is ‪6.26 B‬ CHF, while the previous report showed ‪4.36 B‬ CHF of net income which accounts for 43.50% change. Track more ROCHE HLDGS AG financial stats to get the full picture.
Yes, RHO5 dividends are paid annually. The last dividend per share was 9.60 CHF. As of today, Dividend Yield (TTM)% is 3.76%. Tracking ROCHE HLDGS AG dividends might help you take more informed decisions.
ROCHE HLDGS AG dividend yield was 3.93% in 2023, and payout ratio reached 66.71%. The year before the numbers were 3.27% and 61.19% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 19, 2024, the company has ‪103.61 K‬ employees. See our rating of the largest employees — is ROCHE HLDGS AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ROCHE HLDGS AG EBITDA is ‪19.84 B‬ CHF, and current EBITDA margin is 33.76%. See more stats in ROCHE HLDGS AG financial statements.
Like other stocks, RHO5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ROCHE HLDGS AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ROCHE HLDGS AG technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ROCHE HLDGS AG stock shows the sell signal. See more of ROCHE HLDGS AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.